Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases

Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This stu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & Face Medicine 2024, Vol.20 (1)
Hauptverfasser: Schuderer, Johannes G, Hoferer, Florian, Eichberger, Jonas, Fiedler, Mathias, Gessner, André, Hitzenbichler, Florian, Gottsauner, Maximilian, Maurer, Michael, Meier, Johannes K, Reichert, Torsten E, Ettl, Tobias
Format: Report
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title Head & Face Medicine
container_volume 20
creator Schuderer, Johannes G
Hoferer, Florian
Eichberger, Jonas
Fiedler, Mathias
Gessner, André
Hitzenbichler, Florian
Gottsauner, Maximilian
Maurer, Michael
Meier, Johannes K
Reichert, Torsten E
Ettl, Tobias
description Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This study identifies factors predicting prolonged intravenous antibiotic use and antibiotic escalation in patients receiving free flap head neck reconstruction. A retrospective analysis of 446 patients receiving free flap reconstruction was conducted, examining predictors for antibiotic therapy > 10 days and postoperative escalation. 111 patients (24.8%) experienced escalation, while 159 patients (35.6%) received prolonged therapy. Multivariate regression analysis revealed predictors for escalation: microvascular bone reconstruction (p = 0.008, OR = 2.0), clinically suspected SSI (p < 0.001, OR = 5.4), culture-positive SSI (p = 0.03, OR = 2.9), extended ICU stay (p = 0.01, OR = 1.1) and hospital-acquired pneumonia (p = 0.01, OR = 5.9). Prolonged therapy was associated with bone reconstruction (p = 0.06, OR = 2.0), preoperative irradiation (p = 0.001, OR = 1.9) and culture-positive SSI (p < 0.001, OR = 3.5). The study concludes that SSIs are a primary factor driving the escalation of perioperative antibiotic use. Clinical suspicion of infection often necessitates escalation, even in the absence of confirmed microbiological evidence. Microvascular bone reconstruction was a significant predictor for both the escalation and extension of antibiotic therapy beyond 10 days. Furthermore, preoperative radiation therapy, hospital-acquired pneumonia, and prolonged ICU stay were associated with an increased likelihood of escalation, resulting in significantly extended antibiotic administration during hospitalization. Antibiotic stewardship programmes must be implemented to reduce postoperative antibiotic administration time. Trial registration The study was registered approved by the local Ethics Committee (Nr: 18-1131-104). Keywords: Head neck surgery, Microvascular reconstruction, Perioperative antibiotic prophylaxis, Surgical site infections
doi_str_mv 10.1186/s13005-024-00463-9
format Report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A812304383</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A812304383</galeid><sourcerecordid>A812304383</sourcerecordid><originalsourceid>FETCH-gale_infotracacademiconefile_A8123043833</originalsourceid><addsrcrecordid>eNqVTctOAzEMjBBIlMcPcPIPbEk22aVwQwjEkQMHbshknW5gG6_itFK_hl8lUjlwRZbG9nhmrNSV0UtjVv21GKt11-jWNVq73ja3R2phblzfmF6_Hf-ZT9WZyGcVdV1rFur7JdMQfeEsEDjDnHnitKYBMA1A4nHCUreZcuQKWOKO6q3Ej8gleihjJec9YCiUYRN95h2K306YYSQ85CTyX5DJc5KSt75ETneA4HkzZxopySEUp71EAQ7gXA8eheRCnQSchC5_-7laPj2-Pjw3a5zoPabAJaOvNVD9zYlCrPz9yrRWO7uy9t-GH-V8bI0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases</title><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Schuderer, Johannes G ; Hoferer, Florian ; Eichberger, Jonas ; Fiedler, Mathias ; Gessner, André ; Hitzenbichler, Florian ; Gottsauner, Maximilian ; Maurer, Michael ; Meier, Johannes K ; Reichert, Torsten E ; Ettl, Tobias</creator><creatorcontrib>Schuderer, Johannes G ; Hoferer, Florian ; Eichberger, Jonas ; Fiedler, Mathias ; Gessner, André ; Hitzenbichler, Florian ; Gottsauner, Maximilian ; Maurer, Michael ; Meier, Johannes K ; Reichert, Torsten E ; Ettl, Tobias</creatorcontrib><description>Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This study identifies factors predicting prolonged intravenous antibiotic use and antibiotic escalation in patients receiving free flap head neck reconstruction. A retrospective analysis of 446 patients receiving free flap reconstruction was conducted, examining predictors for antibiotic therapy &gt; 10 days and postoperative escalation. 111 patients (24.8%) experienced escalation, while 159 patients (35.6%) received prolonged therapy. Multivariate regression analysis revealed predictors for escalation: microvascular bone reconstruction (p = 0.008, OR = 2.0), clinically suspected SSI (p &lt; 0.001, OR = 5.4), culture-positive SSI (p = 0.03, OR = 2.9), extended ICU stay (p = 0.01, OR = 1.1) and hospital-acquired pneumonia (p = 0.01, OR = 5.9). Prolonged therapy was associated with bone reconstruction (p = 0.06, OR = 2.0), preoperative irradiation (p = 0.001, OR = 1.9) and culture-positive SSI (p &lt; 0.001, OR = 3.5). The study concludes that SSIs are a primary factor driving the escalation of perioperative antibiotic use. Clinical suspicion of infection often necessitates escalation, even in the absence of confirmed microbiological evidence. Microvascular bone reconstruction was a significant predictor for both the escalation and extension of antibiotic therapy beyond 10 days. Furthermore, preoperative radiation therapy, hospital-acquired pneumonia, and prolonged ICU stay were associated with an increased likelihood of escalation, resulting in significantly extended antibiotic administration during hospitalization. Antibiotic stewardship programmes must be implemented to reduce postoperative antibiotic administration time. Trial registration The study was registered approved by the local Ethics Committee (Nr: 18-1131-104). Keywords: Head neck surgery, Microvascular reconstruction, Perioperative antibiotic prophylaxis, Surgical site infections</description><identifier>ISSN: 1746-160X</identifier><identifier>EISSN: 1746-160X</identifier><identifier>DOI: 10.1186/s13005-024-00463-9</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Analysis ; Bacterial pneumonia ; Care and treatment ; Health aspects ; Infection control ; Pneumonia ; Prevention ; Radiation ; Radiotherapy</subject><ispartof>Head &amp; Face Medicine, 2024, Vol.20 (1)</ispartof><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,860,4476,27902</link.rule.ids></links><search><creatorcontrib>Schuderer, Johannes G</creatorcontrib><creatorcontrib>Hoferer, Florian</creatorcontrib><creatorcontrib>Eichberger, Jonas</creatorcontrib><creatorcontrib>Fiedler, Mathias</creatorcontrib><creatorcontrib>Gessner, André</creatorcontrib><creatorcontrib>Hitzenbichler, Florian</creatorcontrib><creatorcontrib>Gottsauner, Maximilian</creatorcontrib><creatorcontrib>Maurer, Michael</creatorcontrib><creatorcontrib>Meier, Johannes K</creatorcontrib><creatorcontrib>Reichert, Torsten E</creatorcontrib><creatorcontrib>Ettl, Tobias</creatorcontrib><title>Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases</title><title>Head &amp; Face Medicine</title><description>Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This study identifies factors predicting prolonged intravenous antibiotic use and antibiotic escalation in patients receiving free flap head neck reconstruction. A retrospective analysis of 446 patients receiving free flap reconstruction was conducted, examining predictors for antibiotic therapy &gt; 10 days and postoperative escalation. 111 patients (24.8%) experienced escalation, while 159 patients (35.6%) received prolonged therapy. Multivariate regression analysis revealed predictors for escalation: microvascular bone reconstruction (p = 0.008, OR = 2.0), clinically suspected SSI (p &lt; 0.001, OR = 5.4), culture-positive SSI (p = 0.03, OR = 2.9), extended ICU stay (p = 0.01, OR = 1.1) and hospital-acquired pneumonia (p = 0.01, OR = 5.9). Prolonged therapy was associated with bone reconstruction (p = 0.06, OR = 2.0), preoperative irradiation (p = 0.001, OR = 1.9) and culture-positive SSI (p &lt; 0.001, OR = 3.5). The study concludes that SSIs are a primary factor driving the escalation of perioperative antibiotic use. Clinical suspicion of infection often necessitates escalation, even in the absence of confirmed microbiological evidence. Microvascular bone reconstruction was a significant predictor for both the escalation and extension of antibiotic therapy beyond 10 days. Furthermore, preoperative radiation therapy, hospital-acquired pneumonia, and prolonged ICU stay were associated with an increased likelihood of escalation, resulting in significantly extended antibiotic administration during hospitalization. Antibiotic stewardship programmes must be implemented to reduce postoperative antibiotic administration time. Trial registration The study was registered approved by the local Ethics Committee (Nr: 18-1131-104). Keywords: Head neck surgery, Microvascular reconstruction, Perioperative antibiotic prophylaxis, Surgical site infections</description><subject>Analysis</subject><subject>Bacterial pneumonia</subject><subject>Care and treatment</subject><subject>Health aspects</subject><subject>Infection control</subject><subject>Pneumonia</subject><subject>Prevention</subject><subject>Radiation</subject><subject>Radiotherapy</subject><issn>1746-160X</issn><issn>1746-160X</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2024</creationdate><recordtype>report</recordtype><sourceid/><recordid>eNqVTctOAzEMjBBIlMcPcPIPbEk22aVwQwjEkQMHbshknW5gG6_itFK_hl8lUjlwRZbG9nhmrNSV0UtjVv21GKt11-jWNVq73ja3R2phblzfmF6_Hf-ZT9WZyGcVdV1rFur7JdMQfeEsEDjDnHnitKYBMA1A4nHCUreZcuQKWOKO6q3Ej8gleihjJec9YCiUYRN95h2K306YYSQ85CTyX5DJc5KSt75ETneA4HkzZxopySEUp71EAQ7gXA8eheRCnQSchC5_-7laPj2-Pjw3a5zoPabAJaOvNVD9zYlCrPz9yrRWO7uy9t-GH-V8bI0</recordid><startdate>20241015</startdate><enddate>20241015</enddate><creator>Schuderer, Johannes G</creator><creator>Hoferer, Florian</creator><creator>Eichberger, Jonas</creator><creator>Fiedler, Mathias</creator><creator>Gessner, André</creator><creator>Hitzenbichler, Florian</creator><creator>Gottsauner, Maximilian</creator><creator>Maurer, Michael</creator><creator>Meier, Johannes K</creator><creator>Reichert, Torsten E</creator><creator>Ettl, Tobias</creator><general>BioMed Central Ltd</general><scope/></search><sort><creationdate>20241015</creationdate><title>Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases</title><author>Schuderer, Johannes G ; Hoferer, Florian ; Eichberger, Jonas ; Fiedler, Mathias ; Gessner, André ; Hitzenbichler, Florian ; Gottsauner, Maximilian ; Maurer, Michael ; Meier, Johannes K ; Reichert, Torsten E ; Ettl, Tobias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_infotracacademiconefile_A8123043833</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Analysis</topic><topic>Bacterial pneumonia</topic><topic>Care and treatment</topic><topic>Health aspects</topic><topic>Infection control</topic><topic>Pneumonia</topic><topic>Prevention</topic><topic>Radiation</topic><topic>Radiotherapy</topic><toplevel>online_resources</toplevel><creatorcontrib>Schuderer, Johannes G</creatorcontrib><creatorcontrib>Hoferer, Florian</creatorcontrib><creatorcontrib>Eichberger, Jonas</creatorcontrib><creatorcontrib>Fiedler, Mathias</creatorcontrib><creatorcontrib>Gessner, André</creatorcontrib><creatorcontrib>Hitzenbichler, Florian</creatorcontrib><creatorcontrib>Gottsauner, Maximilian</creatorcontrib><creatorcontrib>Maurer, Michael</creatorcontrib><creatorcontrib>Meier, Johannes K</creatorcontrib><creatorcontrib>Reichert, Torsten E</creatorcontrib><creatorcontrib>Ettl, Tobias</creatorcontrib></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schuderer, Johannes G</au><au>Hoferer, Florian</au><au>Eichberger, Jonas</au><au>Fiedler, Mathias</au><au>Gessner, André</au><au>Hitzenbichler, Florian</au><au>Gottsauner, Maximilian</au><au>Maurer, Michael</au><au>Meier, Johannes K</au><au>Reichert, Torsten E</au><au>Ettl, Tobias</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases</atitle><jtitle>Head &amp; Face Medicine</jtitle><date>2024-10-15</date><risdate>2024</risdate><volume>20</volume><issue>1</issue><issn>1746-160X</issn><eissn>1746-160X</eissn><abstract>Literature suggests that intravenous prophylaxis exceeding 48 h offers no additional benefit in preventing surgical site infections (SSI) in patients with microvascular head and neck reconstruction. However, protocols for antibiotic therapy duration post-reconstruction are not standardized. This study identifies factors predicting prolonged intravenous antibiotic use and antibiotic escalation in patients receiving free flap head neck reconstruction. A retrospective analysis of 446 patients receiving free flap reconstruction was conducted, examining predictors for antibiotic therapy &gt; 10 days and postoperative escalation. 111 patients (24.8%) experienced escalation, while 159 patients (35.6%) received prolonged therapy. Multivariate regression analysis revealed predictors for escalation: microvascular bone reconstruction (p = 0.008, OR = 2.0), clinically suspected SSI (p &lt; 0.001, OR = 5.4), culture-positive SSI (p = 0.03, OR = 2.9), extended ICU stay (p = 0.01, OR = 1.1) and hospital-acquired pneumonia (p = 0.01, OR = 5.9). Prolonged therapy was associated with bone reconstruction (p = 0.06, OR = 2.0), preoperative irradiation (p = 0.001, OR = 1.9) and culture-positive SSI (p &lt; 0.001, OR = 3.5). The study concludes that SSIs are a primary factor driving the escalation of perioperative antibiotic use. Clinical suspicion of infection often necessitates escalation, even in the absence of confirmed microbiological evidence. Microvascular bone reconstruction was a significant predictor for both the escalation and extension of antibiotic therapy beyond 10 days. Furthermore, preoperative radiation therapy, hospital-acquired pneumonia, and prolonged ICU stay were associated with an increased likelihood of escalation, resulting in significantly extended antibiotic administration during hospitalization. Antibiotic stewardship programmes must be implemented to reduce postoperative antibiotic administration time. Trial registration The study was registered approved by the local Ethics Committee (Nr: 18-1131-104). Keywords: Head neck surgery, Microvascular reconstruction, Perioperative antibiotic prophylaxis, Surgical site infections</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s13005-024-00463-9</doi></addata></record>
fulltext fulltext
identifier ISSN: 1746-160X
ispartof Head & Face Medicine, 2024, Vol.20 (1)
issn 1746-160X
1746-160X
language eng
recordid cdi_gale_infotracacademiconefile_A812304383
source Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Analysis
Bacterial pneumonia
Care and treatment
Health aspects
Infection control
Pneumonia
Prevention
Radiation
Radiotherapy
title Predictors for prolonged and escalated perioperative antibiotic therapy after microvascular head and neck reconstruction: a comprehensive analysis of 446 cases
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T16%3A52%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Predictors%20for%20prolonged%20and%20escalated%20perioperative%20antibiotic%20therapy%20after%20microvascular%20head%20and%20neck%20reconstruction:%20a%20comprehensive%20analysis%20of%20446%20cases&rft.jtitle=Head%20&%20Face%20Medicine&rft.au=Schuderer,%20Johannes%20G&rft.date=2024-10-15&rft.volume=20&rft.issue=1&rft.issn=1746-160X&rft.eissn=1746-160X&rft_id=info:doi/10.1186/s13005-024-00463-9&rft_dat=%3Cgale%3EA812304383%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A812304383&rfr_iscdi=true